z-logo
open-access-imgOpen Access
Effects of Orally Administered Lactoferrin and Lactoperoxidase-Containing Tablets on Clinical and Bacteriological Profiles in Chronic Periodontitis Patients
Author(s) -
Eiju Shimizu,
Tetsuo Kobayashi,
Hiroyuki Wakabayashi,
Koji Yamauchi,
Keiji Iwatsuki,
Hiromasa Yoshie
Publication year - 2011
Publication title -
international journal of dentistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.61
H-Index - 33
eISSN - 1687-8736
pISSN - 1687-8728
DOI - 10.1155/2011/405139
Subject(s) - lactoperoxidase , lactoferrin , medicine , chronic periodontitis , periodontitis , dentistry , oral administration , chlorhexidine , gastroenterology , peroxidase , enzyme , chemistry , biochemistry
This study was undertaken to evaluate the effect of oral administration of lactoferrin (LF) and lactoperoxidase-(LPO-)containing tablet on periodontal condition. Seventy-two individuals with chronic periodontitis were randomly assigned to take either bovine LF and LPO-containing tablets (test group, n = 37) or control tablets (control group, n = 35) every day for 12 weeks. Periodontal parameters and levels of subgingival plaque bacteria, human and bovine LF, and endotoxin in gingival crevicular fluid (GCF) were evaluated at baseline, 1 week, 4 weeks, and 12 weeks. Significant differences were observed in GCF levels of bovine LF between the test and control groups throughout the study ( P < .05). However, clinical and bacteriological parameter values proved comparable between the two groups at 1 week to 12 weeks. Therefore, the effect of oral administration of LF and LPO-containing tablets might be weak on periodontal and bacteriological profile in this study.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom